Search: onr:"swepub:oai:lup.lub.lu.se:3d865be1-5a19-40bc-b816-c9d1922c96f3" >
Pooled analysis of ...
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
- Article/chapterEnglish2002
Publisher, publication year, extent ...
-
Oxford University Press (OUP),2002
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:3d865be1-5a19-40bc-b816-c9d1922c96f3
-
https://lup.lub.lu.se/record/345780URI
-
https://doi.org/10.1093/jnci/94.2.116DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Background: Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play essential roles in tumor invasion and metastasis. High levels of both uPA and PAT-1 are associated with poor prognosis in breast cancer patients. To confirm the prognostic value of uPA and PAI-1 in primary breast cancer, we reanalyzed individual patient data provided by members of the European Organization for Research and Treatment of Cancer-Receptor and Biomarker Group (EORTC-RBG). Methods: The study included 18 datasets involving 8377 breast cancer patients. During follow-up (median 79 months), 35% of the patients relapsed and 27% died. Levels of uPA and PAI-1 in tumor tissue extracts were determined by different immunoassays; values were ranked within each dataset and divided by the number of patients in that dataset to produce fractional ranks that could be compared directly across datasets. Associations of ranks of uPA and PAI-1 levels with relapse-free survival (RFS) and overall survival (OS) were analyzed by Cox multivariable regression analysis stratified by dataset, including the following traditional prognostic variables: age, menopausal status, lymph node status, tumor size, histologic grade, and steroid hormone-receptor status. All P values were two-sided. Results: Apart from lymph node status, high levels of uPA and PAI-1 were the strongest predictors of both poor RFS and poor OS in the analyses of all patients. Moreover, in both lymph node-positive and lymph nodenegative patients, higher uPA and PAI-1 values were independently associated with poor RFS and poor OS. For (untreated) lymph node-negative patients in particular, uPA and PAI-1 included together showed strong prognostic ability (all P<.001). Conclusions: This pooled analysis of the EORTC-RBG datasets confirmed the strong and independent prognostic value of uPA and PAI-1 in primary breast cancer. For patients with lymph node-negative breast cancer, uPA and PAI-1 measurements in primary tumors may be especially useful for designing individualized treatment strategies.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
van Putten, WLJ
(author)
-
Duffy, MJ
(author)
-
Harbeck, N
(author)
-
Christensen, IJ
(author)
-
Thomssen, C
(author)
-
Kates, R
(author)
-
Spyratos, F
(author)
-
Fernö, MårtenLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)onk-mfe
(author)
-
Eppenberger-Castori, S
(author)
-
Sweep, CGJF
(author)
-
Ulm, K
(author)
-
Peyrat, JP
(author)
-
Martin, PM
(author)
-
Magdelenat, H
(author)
-
Brunner, N
(author)
-
Duggan, C
(author)
-
Lisboa, BW
(author)
-
Bendahl, Pär-OlaLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)onk-pbe
(author)
-
Quillien, V
(author)
-
Daver, A
(author)
-
Ricolleau, G
(author)
-
Meijer-van Gelder, E
(author)
-
Manders, P
(author)
-
Fiets, WE
(author)
-
Blankenstein, MA
(author)
-
Broet, P
(author)
-
Romain, S
(author)
-
Daxenbichler, G
(author)
-
Windbichler, G
(author)
-
Cufer, T
(author)
-
Borstnar, S
(author)
-
Kueng, W
(author)
-
Beex, LVAM
(author)
-
Klijn, JGM
(author)
-
O'Higgins, N
(author)
-
Eppenberger, U
(author)
-
Janicke, F
(author)
-
Schmitt, M
(author)
-
Foekens, JA
(author)
-
Bröstcancer-genetikSektion I
(creator_code:org_t)
Related titles
-
In:Journal of the National Cancer Institute: Oxford University Press (OUP)94:2, s. 116-1281460-21050027-8874
Internet link
Find in a library
To the university's database
- By the author/editor
-
Look, MP
-
van Putten, WLJ
-
Duffy, MJ
-
Harbeck, N
-
Christensen, IJ
-
Thomssen, C
-
show more...
-
Kates, R
-
Spyratos, F
-
Fernö, Mårten
-
Eppenberger-Cast ...
-
Sweep, CGJF
-
Ulm, K
-
Peyrat, JP
-
Martin, PM
-
Magdelenat, H
-
Brunner, N
-
Duggan, C
-
Lisboa, BW
-
Bendahl, Pär-Ola
-
Quillien, V
-
Daver, A
-
Ricolleau, G
-
Meijer-van Gelde ...
-
Manders, P
-
Fiets, WE
-
Blankenstein, MA
-
Broet, P
-
Romain, S
-
Daxenbichler, G
-
Windbichler, G
-
Cufer, T
-
Borstnar, S
-
Kueng, W
-
Beex, LVAM
-
Klijn, JGM
-
O'Higgins, N
-
Eppenberger, U
-
Janicke, F
-
Schmitt, M
-
Foekens, JA
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Journal of the N ...
- By the university
-
Lund University